Use of 5-HT3 receptor antagonists to prevent nausea and emesis caused by chemotherapy for patients with breast carcinoma in community practice settings.

Source:http://linkedlifedata.com/resource/pubmed/id/10391565

Cancer 1999 Jul 1 86 1 64-71

Download in:

View as

General Info

PMID
10391565